Mandibular Advancement to Reduce Ventricular Load and Improve Quality-of-life in Heart Failure

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 328 participants.

Also called NCT07460505

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 328 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07460505
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Singapore (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07460505. Randomized; triple masking; primary purpose treatment. Start 2026-05-01 (anticipated); primary completion 2031-04-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Mandibular Advancement to Reduce Ventricular Load and Improve Quality-of-life in Heart Failure
Acronym
MARVEL-HF
Condition
Heart Failure
Condition
OSA - Obstructive Sleep Apnea
Intervention (Device)
Mandibular advancement device
Intervention (Device)
Mandibular advancement device (Sham)
Lead sponsor
National University Hospital, Singapore (class: other)
Collaborator
Alexandra Hospital (class: other)
Collaborator
Ng Teng Fong General Hospital (class: other)

Record details

Record id
cardio:ct-nct07460505
Content hash
ecc1bca1b30c038c5c2e27ac36fe2b598b18a3a5c5c6b81a20a8f65e9bbd95ae